This also applies to those with endocrine neoplasia syndrome type 2 (MEN 2)
(B) C-peptide response to hyperglycemia, GLP-1 infusion, and GIP infusion in subjects with type 2 diabetes before and after dapagliflozin treatment (magnified from Fig
Researchers started 1,613 adults in the trial on 1 mg of orforglipron and increased the dose every four weeks until patients received 6 mg, 12 mg, and 36 mg, while other patients received a placebo
If weight management is your primary concern alongside type 2 diabetes, speak with your prescriber about Mounjaro (tirzepatide), which is licensed for both type 2 diabetes and weight management and has been shown to produce greater results than either Ozempic or Trulicity
As you reach your weight loss goal, your nutrition needs will change so having the right support in place can help you maintain a healthy weight and prevent weight cycling in the long term
recommended as a prescription-only substance